U.S. markets closed
  • S&P Futures

    3,830.50
    +21.25 (+0.56%)
     
  • Dow Futures

    31,040.00
    +128.00 (+0.41%)
     
  • Nasdaq Futures

    12,997.50
    +86.50 (+0.67%)
     
  • Russell 2000 Futures

    2,224.70
    +25.50 (+1.16%)
     
  • Crude Oil

    62.39
    +0.89 (+1.45%)
     
  • Gold

    1,735.20
    +6.40 (+0.37%)
     
  • Silver

    26.78
    +0.34 (+1.30%)
     
  • EUR/USD

    1.2092
    -0.0094 (-0.77%)
     
  • 10-Yr Bond

    1.4600
    -0.0580 (-3.82%)
     
  • Vix

    27.95
    -0.94 (-3.25%)
     
  • GBP/USD

    1.3973
    -0.0040 (-0.29%)
     
  • USD/JPY

    106.4850
    +0.2550 (+0.24%)
     
  • BTC-USD

    45,467.11
    -1,092.53 (-2.35%)
     
  • CMC Crypto 200

    912.88
    -20.25 (-2.17%)
     
  • FTSE 100

    6,483.43
    -168.53 (-2.53%)
     
  • Nikkei 225

    28,966.01
    -1,202.29 (-3.99%)
     

SHAREHOLDER ALERT: BABA NERV TCDA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / January 11, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Alibaba Group Holding Limited (NYSE:BABA)

If you suffered a loss, contact us at:http://www.wongesq.com/pslra-1/alibaba-group-holding-limited-loss-submission-form?prid=12059&wire=1
Lead Plaintiff Deadline: January 12, 2021
Class Period: July 9, 2020 - December 23, 2020

Allegations against BABA include that: (1) Ant Small and Micro Financial Services Group Co., Ltd. ("Ant Group"), a financial technology company in which Alibaba owns a 33% equity interest, did not meet listing qualifications or disclosure requirements for certain material matters; (2) certain impending changes in the Fintech regulatory environment would impact Ant Group's business; (3) as a result of the foregoing, Ant Group's initial public offering was reasonably likely to be suspended; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Minerva Neurosciences, Inc. (NASDAQ:NERV)

If you suffered a loss, contact us at:http://www.wongesq.com/pslra-1/minerva-neurosciences-inc-loss-submission-form?prid=12059&wire=1
Lead Plaintiff Deadline: February 8, 2021
Class Period: May 15, 2017 - November 30, 2020

Allegations against NERV include that: (i) the truth about the feedback received from the FDA concerning the "end-of-Phase 2" meeting; (ii) the Phase 2b study did not use the commercial formulation of roluperidone and was conducted solely outside of the United States; (iii) the failure of the Phase 3 study to meet its primary and key secondary endpoints rendered that study incapable of supporting substantial evidence of effectiveness; (iv) the Company's plan to use the combination of the Phase 2b and Phase 3 studies would be "highly unlikely" to support the submission of an NDA; (v) reliance on these two trials in the submission of an NDA would lead to "substantial review issues" because the trials were inadequate and not well-controlled; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times.

Tricida, Inc. (NASDAQ:TCDA)

If you suffered a loss, contact us at:http://www.wongesq.com/pslra-1/tricida-inc-loss-submission-form?prid=12059&wire=1
Lead Plaintiff Deadline: March 8, 2021
Class Period: September 4, 2019 - October 28, 2020

Allegations against TCDA include that: (i) Tricida's NDA for veverimer was materially deficient; (ii) accordingly, it was foreseeably likely that the FDA would not accept the NDA for veverimer; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong



View source version on accesswire.com:
https://www.accesswire.com/623778/SHAREHOLDER-ALERT-BABA-NERV-TCDA-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines